Cc chemokine receptor 9 (ccr9) antagonist ameliorates experimental ileitis and colitis

Samankaltaisia teoksia

• CCR9 Antagonists in the Treatment of Ulcerative Colitis
  Tekijä: Pirow Bekker, et al.
  Julkaistu: (2015-01-01)
• MEDI 167-Discovery of the highly potent, selective and orally bioavailable CCR9 antagonist CCX282-B
  Tekijä: Ungashe, S, et al.
  Julkaistu: (2008)
• Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.
  Tekijä: Walters, M, et al.
  Julkaistu: (2010)
• Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease
  Tekijä: Keshav, S, et al.
  Julkaistu: (2007)
• Traficet-EN (CCX282-B), an orally active inhibitor of chemokine receptor CCR9, for treatment of Crohn's disease
  Tekijä: Bekker, P, et al.
  Julkaistu: (2007)